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The spin trapping ESR technique was applied to investigate oxygen-derived radicals in ischemic and post- 
ischemic rat hearts. Using 5,5’-dimethyl-I-pyrroline-N-oxide, carbon-centered radicals were identified dur- 
mg ischemia and oxy-radical adducts (superoxide anion radical, O;- and hydroxyl radicals, ‘OH) in post- 
ischemic rat heart. The formation of these spin adducts was inhibited by superoxide dismutase, suggesting 
that superoxide plays a role in the adducts’ formation. The results demonstrate that oxygen derived free 
radicals are important byproducts of abnormal oxidative metabolism during myocardial ischemic and reper- 
fusion injuries. 
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1. INTRODUCTION 
It has been suggested that during myocardial 
ischemia short-lived free radicals such as superox- 
ide (Oi- ), hydroxyl (‘OH), or lipid peroxide (RO’) 
are produced. The evidence, however, for the par- 
ticipation of such radicals in cardiovascular injury 
has been based upon activation of lipid peroxida- 
tion and on myocardial protection provided by 
scavengers [1,2]. Direct detection of free radicals 
by electron spin resonance (ESR) spectroscopy has 
not provided conclusive identification of radicals 
produced during these injuries [3]. However, spin 
trapping and ESR offers an indirect technique that 
provides the necessary evidence to confirm the in- 
volvement of these labile intermediates. Although 
spin trapping has been applied very successfully to 
studies of free radical mechanisms in a variety of 
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chemical and photochemical reactions, it has only 
recently been applied to biological systems [4]. The 
majority of the spin traps used are molecules con- 
taining a nitroso or nitrone group which, upon ad- 
dition of a labile free radical, form a stable 
nitroxide that is easily detected by ESR. We ap- 
plied spin trapping to study biologically generated 
free radicals in ischemic and post-ischemic rat 
hearts. We detected a 5,5’-dimethyl-I-pyrroline-N- 
oxide (DMPO)-carbon radical and DMPO-OH ad- 
ducts during ischemia. Furthermore, during post- 
ischemic myocardial reperfusion we observed oxy- 
radical adducts (superoxide anion and hydroxyl 
radical). The formation of these three different 
spin adducts was inhibited by superoxide dis- 
mutase (SOD), suggesting that formation of the 
adducts (DMPO-OH and DMPO-carbon) involves 
superoxide as a precursor. 
2. MATERIALS AND METHODS 
DMPO was obtained from Aldrich and was pu- 
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rified according to the method of Buettner and 
Oberley [5] by repeatedly treating the solution with 
activated charcoal until all the free radical im- 
purities were eliminated. The concentrations of the 
aqueous DMPO solutions were determined spec- 
trophotometrically at 227 nm (e = 8 x lo3 M-l. 
cm-‘) [6]. The experimental room was kept in 
darkness throughout the study to prevent 
photolytic degradation of DMPO. 
Male Sprague-Dawley rats (200-224 g) were 
decapitated and their hearts were cannulated 
within 1 min after excision. The perfusion ap- 
paratus used has been described [7]. The hearts 
were perfused (non-recirculating) at 37°C with 
physiological Krebs-Henseleit buffer containing 
5 mM glucose and 5 mM sodium acetate in the 
presence or absence of DMPO. The perfusate was 
aerated with a 95% 02/5% COZ gas mixture to 
maintain a pH of 7.4. Rat hearts were stabilized 
under control perfusion conditions for 20 min 
prior to induction of global ischemia. 
Global ischemia was carried out by perfusing 
hearts with buffer containing DMPO at a low- 
coronary flow rate (0.1 ml/min) for 40 min. Cor- 
onary effluents containing the spin trap were im- 
mediately frozen in liquid Nz to prevent spin 
adduct decay. In post-ischemic reperfusion ex- 
periments, hearts were exposed to DMPO during 
the last 5 min of ischemia and subsequent reperfu- 
sion; again coronary effluents containing DMPO 
were immediately frozen in liquid Nz. 
Frozen samples were thawed just before their 
ESR spectra were obtained. Control experiments 
showed that when solutions containing DMPO ad- 
ducts were frozen and stored for 5 h at liquid 
nitrogen temperature, there was no significant loss 
in the ESR signal of these spin adducts if the ESR 
spectra were obtained immediately after thawing. 
ESR measurements were made on a Bruker-ER 
100 series, X-band spectrometer using a magnetic 
field modulation frequency of 100 kHz. The ESR 
spectra were obtained using a quartz flat cell 
(60 x 10 x 0.25 mm). 
The microwave power was maintained at 10 mW 
to avoid saturation, and the scan was traced with 
a modulation equal to 1 G. Hyperfine coupling 
constants were measured directly from the field 
scan using a 10 G marker signal for calibration. 
In some cases superoxide dismutase (EC 
1.15.1.1; Sigma) was administered in the perfusion 
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medium containing DMPO during ischemia and 
reperfusion. 
3. RESULTS 
Despite numerous experimental artifacts 
associated with the use of DMPO as a ‘universal’ 
spin trap [5], DMPO appears to be an optimal 
choice in view of its low cytotoxicity, accessibility 
to the cell, and a high rate constant of reaction 
with ‘OH radicals [g-15]. Purified DMPO solu- 
tions were used to test ischemic rat hearts for their 
capacity to generate Oi-or ‘OH radicals. After 
40 min of pre-ischemic perfusion in the presence of 
DMPO, no signal was observed. 
When global ischemia was carried out in the 
presence of 100 mM DMPO, the ESR spectra of 
the coronary effluent indicated that two free 
radical adducts were formed (fig.1). One of the 
radicals appears to be ‘OH and its generation is 
dependent on the presence of 02 (DMPO-OH, 
AN = 1.49 mT; A& = 1.49 mT). The other spin- 
trapped radical is a derivative of an unknown car- 
bon compound and its formation is decreased by 
the presence of oxygen. The hyperfine constants 
are AN = 1.55 mT and A& = 2.26 mT for the 
5G 
- 
a. DMPO-OH ADDUCT 
b DMPO-CARBON RADICAL ADDUCT 
Fig.1. ESR spectra of DMPO adducts in &hernia rat 
heart. Hearts were subjected to 40 min of global 
ischemia in the presence of 100 mM DMPO. Scan time 
4 min; receiver gain 1.25 f 105; modulation amplitude 
0.5 G. 
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DMPO-carbon radical adduct. Similar coupling 
constants have been reported for carbon-centered 
radical adducts from lipid peroxidation [16-181 
varying from 1.5 to 1.6 mT for AN and 2.26 to 
2.32 for A&. Besides the possibility that DMPO 
itself could lead to a similar signal [ 181, our results 
support the assumption that the carbon-centered 
radicals might be derived from lipid peroxidation. 
Fig.2 shows that the carbon radical could be in- 
hibited by administration of SOD during global 
ischemia. The inhibition of the ESR signal suggests 
that the superoxide anion is the precursor of this 
carbon-centered radical adduct. Furthermore, no 
ESR signals were observed during the first 15 min 
of global ischemia when SOD was added to the 
system (fig.2B); however, after 15 min a very weak 
signal started to appear at a g value of 2.0052. The 
ESR signal observed was identified as ascorbyl free 
radical with a g value of 2.0052 and splitting of 
0.17 mT as shown in fig.2C. 
Post-ischemic, reperfused rat hearts in the 
presence of DMPO resulted in the formation of 
different paramagnetic species (fig.3). In the 
absence of DMPO, no ESR signal spectrum was 
observed. Spectrum A, obtained 20 s after reperfu- 
sion was initiated, can be attributed to DMPO- 
OOH adducts (AN = 1.425 mT; A& = 1.13 mT, 
A 
Fig.2. ESR spectra obtained: (A) 10 min of ischemia 
without SOD; (B) 10 min of &hernia in the presence of 
SOD (93 pug/ml); (C) 30 min of &hernia in the presence 
of SOD (ESR signal of the ascorbyl free radical). Scan 
time 4 min; receiver gain 2 x IO’; modulation amplitude 
0.5 G. 
DMPO-Superoxlde 
SOD-Inhlblted 
Fig.3. Transition of the ESR spectra from the DMPO- 
OOH adduct to the DMPO-OH adduct as a function of 
time. Samples were taken (A) 20 s, (B) 1 min and (C) 
3 min in the presence of SOD (93 pg/ml) after reperfu- 
sion was initiated. Scan time 4 min; receiver gain 
1.25 x 10’; modulation amplitude 0.5 G. 
A& = 0.14 mT). 1 min after reperfusion was in- 
itiated, the initial adduct appeared to decompose 
to DMPO-OH species (fig.3B). SOD was found to 
interfere with this process by inhibiting the forma- 
tion of the DMPO-OOH adduct. This observation 
agrees with the work of others [19] and indicates 
another source of generation of DMPO-OH ad- 
ducts without the obligatory formation of free 
‘OH radicals. Therefore, the data suggest that 
Oi- (and HOi) are initially trapped by DMPO. 
Half-life values of 80 s at pH 6 and approx. 35 s 
at pH 8 [5] have been reported for the DMPO- 
OOH adduct. 
4. DISCUSSION 
A number of mechanisms have been proposed to 
generate Oi- in post-ischemic myocardium. Dur- 
ing ischemia, high concentrations of hypoxanthine 
accumulate due to the degradation of ATP [19]. 
Metabolism of this nucleotide is normally 
mediated by xanthine dehydrogenase; during 
ischemia, however, this enzyme is converted to the 
oxidase form which reduces 02 forming Oi- [20]. 
Other possible sources of Oi- include mitochon- 
drial oxication [21], oxidation of catecholamines 
released locally during ischemia [22], and genera- 
tion by polymorphonuclear leukocytes which 
migrate to the ischemic tissue [23]. 
In our blood-free perfused heart model it is 
unlikely that sufficient numbers of polymorpho- 
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nuclear leukocytes would remain to account for 
the observed oxygen radical formation. Neverthe- 
less, we have no evidence indicating the cellular or 
subcellular source of the superoxide anion. Clear- 
ly, further work is needed to identify the actual 
mechanisms of Oigeneration in reperfused myo- 
cardium and quantitate the contributions of each 
mechanism. 
One consequence of enhanced radical generation 
is an increase in peroxidation of lipids. Free radical 
production is involved in lipid peroxidation, this 
has been indicated by accumulation of products of 
this pathway in the ischemic heart [24]. Therefore, 
peroxidizing lipids can be assumed to be an addi- 
tional radical source during ischemia. The ap- 
pearance of the DMPO carbon-centered adduct 
during global ischemia suggests that lipid radicals 
can be released from the ischemic myocardium. 
The absence of a detectable DMPO-OOH ESR 
signal during global ischemia does not negate the 
presence of a small amount of superoxide in the 
process, but merely define the stability of the spin 
adduct under the experimental conditions used. 
This was supported by the observation that SOD 
completely inhibited the spin adducts’ formation 
during ischemia and reperfusion. This observation 
suggests that oxygen-radicals induce peroxidation 
of lipids, and may lead to membrane dysfunctions 
during tissue injury. Direct evidence of tissue in- 
jury was suggested by the presence of ascorbyl free 
radical during global ischemia. 
Our results demonstrate that short-lived free 
radicals, superoxide anion, hydroxyl, and carbon- 
centered radicals, are formed during myocardial 
ischemia and post-ischemic reperfusion. We 
definitely demonstrate that superoxide anion is 
produced during the early phase of reperfusion. 
These studies provide direct evidence of the validi- 
ty of the free radical hypothesis of ischemia- 
reperfusion cell injury. 
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